Vinva Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
243,260
+138,135
| +131% | +$6.4M | 0.29% | 86 |
|
|
2025
Q1 | $6.31M | Sell |
105,125
-8,810
| -8% | -$529K | 0.25% | 106 |
|
|
2024
Q4 | $6.39M | Sell |
113,935
-18,166
| -14% | -$1.02M | 0.24% | 97 |
|
|
2024
Q3 | $6.73M | Buy |
132,101
+17,231
| +15% | +$877K | 0.28% | 86 |
|
|
2024
Q2 | $4.77M | Buy |
114,870
+29,472
| +35% | +$1.22M | 0.24% | 101 |
|
|
2024
Q1 | $4.63M | Buy |
85,398
+5,723
| +7% | +$310K | 0.26% | 97 |
|
|
2023
Q4 | $4.08M | Buy |
79,675
+2,352
| +3% | +$120K | 0.28% | 88 |
|
|
2023
Q3 | $4.5M | Buy |
77,323
+925
| +1% | +$53.8K | 0.42% | 55 |
|
|
2023
Q2 | $4.89M | Buy |
76,398
+3,593
| +5% | +$230K | 0.42% | 55 |
|
|
2023
Q1 | $4.97M | Buy |
+72,805
| New | +$4.97M | 0.41% | 63 |
|